A newly approved alternative to warfarin, a drug called dabigatran (sold under the brand name Pradaxa), fights stroke better than warfarin, with less bleeding into the brain, among people with atrial fibrillation. It could also make life a little bit easier for them. Pradaxa is not affected by diet and does not require its dosage to be fine-tuned. For some people, switching right away to Pradaxa makes sense. For others, it is worth adopting a watch-and-wait strategy. Talk with your doctor to see which approach is right for you.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.